Elite Pharma Stock Market Value
| ELTP Stock | USD 0.50 0.02 4.17% |
| Symbol | Elite |
Elite Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Elite Pharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Elite Pharma.
| 01/01/2025 |
| 12/27/2025 |
If you would invest 0.00 in Elite Pharma on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Elite Pharma or generate 0.0% return on investment in Elite Pharma over 360 days. Elite Pharma is related to or competes with AB Science, Swedencare, Glass House, Allergy Therapeutics, and Basilea Pharmaceutica. Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, con... More
Elite Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Elite Pharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Elite Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 19.71 | |||
| Value At Risk | (4.84) | |||
| Potential Upside | 3.39 |
Elite Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elite Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Elite Pharma's standard deviation. In reality, there are many statistical measures that can use Elite Pharma historical prices to predict the future Elite Pharma's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | (0.40) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elite Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Elite Pharma Backtested Returns
Elite Pharma secures Sharpe Ratio (or Efficiency) of -0.15, which denotes the company had a -0.15 % return per unit of risk over the last 3 months. Elite Pharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Elite Pharma's Mean Deviation of 1.96, standard deviation of 2.95, and Variance of 8.73 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.13, which means a somewhat significant risk relative to the market. Elite Pharma returns are very sensitive to returns on the market. As the market goes up or down, Elite Pharma is expected to follow. At this point, Elite Pharma has a negative expected return of -0.44%. Please make sure to confirm Elite Pharma's maximum drawdown, as well as the relationship between the accumulation distribution and market facilitation index , to decide if Elite Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.58 |
Good reverse predictability
Elite Pharma has good reverse predictability. Overlapping area represents the amount of predictability between Elite Pharma time series from 1st of January 2025 to 30th of June 2025 and 30th of June 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Elite Pharma price movement. The serial correlation of -0.58 indicates that roughly 58.0% of current Elite Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.58 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Elite Pharma lagged returns against current returns
Autocorrelation, which is Elite Pharma otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Elite Pharma's otc stock expected returns. We can calculate the autocorrelation of Elite Pharma returns to help us make a trade decision. For example, suppose you find that Elite Pharma has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Elite Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Elite Pharma otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Elite Pharma otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Elite Pharma otc stock over time.
Current vs Lagged Prices |
| Timeline |
Elite Pharma Lagged Returns
When evaluating Elite Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Elite Pharma otc stock have on its future price. Elite Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Elite Pharma autocorrelation shows the relationship between Elite Pharma otc stock current value and its past values and can show if there is a momentum factor associated with investing in Elite Pharma.
Regressed Prices |
| Timeline |
Additional Tools for Elite OTC Stock Analysis
When running Elite Pharma's price analysis, check to measure Elite Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elite Pharma is operating at the current time. Most of Elite Pharma's value examination focuses on studying past and present price action to predict the probability of Elite Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elite Pharma's price. Additionally, you may evaluate how the addition of Elite Pharma to your portfolios can decrease your overall portfolio volatility.